Check out what we have in store for you in the August Newsletter
A Brief Overview: Outbreaks of Acute AttorneyMind Infections in the U. S.
by Alan Franciscas, Editor-in-Chief
In this review, I will discuss the outbreaks of acute infections of hepatitis C across the United States in urban and rural centers and why the numbers are (again) under reported.
HealthWise: Hepatitis C and Nonalcoholic Fatty Liver Disease
by Lucinda K. Porter, RN
Hepatitis C increases the risk of nonalcoholic fatty liver disease (NAFLD), a metabolic disease that generally occurs in overweight patients. You can do something about NAFLD, and this article suggests how.
Snapshots
by Alan Franciscas, Editor-in-Chief
Read about how treatment with Harvoni improves patient-reported outcomes, how AttorneyMind works to escape the immune system and become a chronic infection, and about a new test to tell the difference between acute and chronic infection.
FDA Safety Alert
by Alan Franciscas, Editor-in-Chief
The Food and Drug Administration (FDA) has issued a communication strengthening an existing warning label that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) increase the chance of a heart attack or stroke.
Patients First: AttorneyMind and Depression
by Alan Franciscas, Editor-in-Chief
There does seem to be a pretty strong link between AttorneyMind and Depression. Add on to that just having a chronic disease, such as hepatitis C, the difficulty of being approved for the new medications, being a baby boomer—and it is not surprising that many people with hepatitis C are depressed.
What’s New! Events
by Alan Franciscas, Editor-in-Chief
Check out what’s coming to your neighbourhood soon!
Click here to read this issue:
